Cancer microenvironment and pharmacological interventions
- PMID: 38148105
- DOI: 10.1111/bph.16279
Cancer microenvironment and pharmacological interventions
References
REFERENCES
-
- Borzone, F. R., Giorello, M. B., Sanmartin, M. C., Yannarelli, G., Martinez, L. M., & Chasseing, N. A. (2023). Mesenchymal stem cells and cancer-associated fibroblasts as a therapeutic strategy for breast cancer. British Journal of Pharmacology, 181(2), 238-256. https://doi.org/10.1111/bph.15861
-
- Cassetta, L., & Pollard, J. W. (2018). Targeting macrophages: Therapeutic approaches in cancer. Nature Reviews Drug Discovery, 17, 887-904. https://doi.org/10.1038/nrd.2018.169
-
- Dainiak, M. B., Savina, I. N., Musolino, I., Kumar, A., Mattiasson, B., & Galaev, I. Y. (2008). Biomimetic macroporous hydrogel scaffolds in a high-throughput screening format for cell-based assays. Biotechnology Progress, 24, 1373-1383. https://doi.org/10.1002/btpr.30
-
- Himes, B. T., Peterson, T. E., De Mooij, T., Garcia, L. M. C., Jung, M. Y., Uhm, S., Yan, D., Tyson, J., Jin-Lee, H. J., Parney, D., Abukhadra, Y., Gustafson, M. P., Dietz, A. B., Johnson, A. J., Dong, H., Maus, R. L., Markovic, S., Lucien, F., & Parney, I. F. (2020). The role of extracellular vesicles and PD-L1 in glioblastoma-mediated immunosuppressive monocyte induction. Neuro-Oncology, 22, 967-978. https://doi.org/10.1093/neuonc/noaa029
-
- Martinez, L. M., & Guzman, M. L. (2023). Understanding the interaction between leukaemia stem cells and their microenvironment to improve therapeutic approaches. British Journal of Pharmacology, 181(2), 273-282. https://doi.org/10.1111/bph.16162
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical